(table only in thousands)	Three months ended March 31, 2020						Year ended December 31, 2019
Goodwill / Tradename	Goodwill			Tradename			Goodwill			Tradename
Beginning balance	$	152,020		$	14,291		$	152,156		$	18,258
Transfers to finite life classification		—			—			—			(3,904	)
Foreign currency translation		(344	)		(49	)		(136	)		(63	)
	$	151,676		$	14,242		$	152,020		$	14,291

(table only in thousands)	As of March 31, 2020						As of December 31, 2019
Intangible assets – finite life	Cost			Accum. Amort.			Cost			Accum. Amort.
Technology	$	14,457		$	11,267		$	14,457		$	10,686
Customer lists		68,943			45,484			68,943			44,484
Tradename		5,294			1,286			5,294			1,154
Foreign currency adjustments		(1,691	)		(494	)		(1,869	)		(782	)
	$	87,003		$	57,543		$	86,825		$	55,542

(table only in thousands)	2020			2019
Intangible assets – finite life, net at beginning of period	$	31,283		$	35,959
Amortization expense		(1,713	)		(2,160	)
Transfers from indefinite life classification		—			3,904
Foreign currency adjustments		(110	)		(70	)
Intangible assets – finite life, net at end of period	$	29,460		$	37,633

Amortization expense of finite life intangible assets was $1.7 million and $2.2 million for the three-month periods ended March 31, 2020 and 2019, respectively. Amortization over the next five years for finite life intangibles is expected to be $5.1 million for the remainder of 2020, $5.7 million in 2021, $4.8 million in 2022, $4.0 million in 2023, and $3.4 million in 2024.

During the three-month period ended March 31, 2019, the Company reassessed the useful lives of certain tradenames and determined that $3.9 million of their tradenames would have useful lives of 10 years now versus indefinite.

The Company completes an annual (or more often if circumstances require) goodwill and indefinite life intangible asset impairment assessment on October 1. As a part of its impairment assessment, the Company first qualitatively assesses whether current events or changes in circumstances lead to a determination that it is more likely than not (defined as a likelihood of more than 50 percent) that the fair value of a reporting unit or indefinite life intangible asset is less than its carrying amount. If there is a qualitative determination that the fair value is more likely than not greater than carrying value, the Company does not need to quantitatively test for impairment. If this qualitative assessment indicates a more likely than not potential that the asset may be impaired, the estimated fair value is calculated. If the estimated fair value is less than carrying value, an impairment charge is recorded.

In 2019, we performed a quantitative assessment and concluded each of our reporting units and indefinite life intangible assets had excess fair value over their carrying value. However, as of March 31, 2020, we observed negative macroeconomic indicators resulting from the COVID-19 pandemic, which could have a direct impact on our business. We determined this constituted a triggering event that required an assessment to determine if an impairment loss may have occurred. Therefore, we qualitatively assessed whether it was more likely than not that goodwill and indefinite life intangible assets were impaired as of March 31, 2020. We reviewed our previous forecasts and assumptions based on our current projections, which are subject to various risks and uncertainties, including projected revenue, projected operational profit, terminal growth rates, and the cost of capital. Based on our interim impairment assessment as of March 31, 2020, we have determined that our goodwill and indefinite life intangible assets are not impaired. The Company’s assumptions about future conditions important to its assessment of potential impairment of its goodwill and indefinite life intangible assets, including the impacts of the COVID-19 pandemic, are subject to uncertainty, and the Company will continue to monitor these conditions in future periods as new information becomes available, and will update its analyses accordingly.